Home > Insider Trading > Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc. (MIST)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

Displaying 5

Hedge Fund and Insider Trading News: Daniel Och, Bill Ackman, Daniel Loeb, David Einhorn, Saba Capital Management, Brookfield Asset Management, Milestone Pharmaceuticals Inc (MIST), Axcella Health Inc. (AXLA), and More

The hedge fund firm formerly known as Och-Ziff "deteriorated" under the "mismanagement" of its founder Daniel Och, forcing those who succeeded him to spend years stabilizing the Wall Street firm, the ...

Keep Reading →

October 24th, 2022 - Hedge Funds Insider Trading

10 Stocks to Buy According to Neil Shahrestani's Ikarian Capital

In this article, we will take a look at the 10 stocks to buy according to Neil Shahrestani's Ikarian Capital.

Keep Reading →

August 3rd, 2021 - Hedge Funds News

Is Milestone Pharmaceuticals (MIST) A Good Stock To Buy Now?

In this article we will take a look at whether hedge funds think Milestone Pharmaceuticals Inc. (NASDAQ:MIST) is a good investment right now.

Keep Reading →

December 2nd, 2020 - Hedge Funds News

Milestone Pharmaceuticals Inc. (MIST): Are Hedge Funds Right About This Stock?

The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter.

Keep Reading →

June 5th, 2020 - Hedge Funds News